Skip to Content

Drug Safety Newsletter – Edition 113 – 3 November 2023

03/11/2023
Medicines for human use Safety update

The latest edition of the HPRA Drug Safety Newsletter (edition 113) includes important updates to support the safe and appropriate use of the following medicines:

Topiramate: Introduction of a pregnancy prevention programme and new restrictions on use.

Valproate (Epilim): Ongoing review of potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the three months prior to conception

Documents

Opens in new window Drug Safety Newsletter Issue 113 Nov 2023 PDF : 628KB | 23/07/2024